These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 32117427)
1. A Three-Gene Classifier Associated With MicroRNA-Mediated Regulation Predicts Prostate Cancer Recurrence After Radical Prostatectomy. Cheng B; He Q; Cheng Y; Yang H; Pei L; Deng Q; Long H; Zhu L; Jiang R Front Genet; 2019; 10():1402. PubMed ID: 32117427 [TBL] [Abstract][Full Text] [Related]
2. A Novel Set of Immune-associated Gene Signature predicts Biochemical Recurrence in Localized Prostate Cancer Patients after Radical Prostatectomy. Luan JC; Zhang QJ; Zhao K; Zhou X; Yao LY; Zhang TT; Zeng TY; Xia JD; Song NH J Cancer; 2021; 12(12):3715-3725. PubMed ID: 33995646 [No Abstract] [Full Text] [Related]
3. Clinical and Biological Significance of DNA Methylation-Driven Differentially Expressed Genes in Biochemical Recurrence After Radical Prostatectomy. Luo C; He S; Zhang H; He S; Qi H; Wei A Front Genet; 2022; 13():727307. PubMed ID: 35186021 [No Abstract] [Full Text] [Related]
4. Predictive Value of Preoperative Prostate Health Index and Serum Testosterone Testing for Biochemical Recurrence after Radical Prostatectomy for Non-Metastatic Prostate Cancer. Zhang C; Zhang Y; Niu N; Fu G Arch Esp Urol; 2023 Dec; 76(10):787-795. PubMed ID: 38186072 [TBL] [Abstract][Full Text] [Related]
5. A Novel Apoptosis-Related Gene Signature Predicts Biochemical Recurrence of Localized Prostate Cancer After Radical Prostatectomy. Zhang Q; Zhao K; Song L; Ji C; Cong R; Luan J; Zhou X; Xia J; Song N Front Genet; 2020; 11():586376. PubMed ID: 33329725 [No Abstract] [Full Text] [Related]
6. A Novel Predictor Tool of Biochemical Recurrence after Radical Prostatectomy Based on a Five-MicroRNA Tissue Signature. Zhao Z; Weickmann S; Jung M; Lein M; Kilic E; Stephan C; Erbersdobler A; Fendler A; Jung K Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31640261 [TBL] [Abstract][Full Text] [Related]
7. Identification and Validation of a Prognostic 5-Protein Signature for Biochemical Recurrence Following Radical Prostatectomy for Prostate Cancer. Lv D; Cao Z; Li W; Zheng H; Wu X; Liu Y; Gu D; Zeng G Front Surg; 2021; 8():665115. PubMed ID: 34136527 [No Abstract] [Full Text] [Related]
8. Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profiling. Kristensen H; Thomsen AR; Haldrup C; Dyrskjøt L; Høyer S; Borre M; Mouritzen P; Ørntoft TF; Sørensen KD Oncotarget; 2016 May; 7(21):30760-71. PubMed ID: 27120795 [TBL] [Abstract][Full Text] [Related]
9. Establishment of a molecular risk model for the prognosis of cervical cancer based on microRNA expression. Li J; Liang L; Xiu L; Zeng J; Zhu Y; An J; Wu L Ann Transl Med; 2022 Jan; 10(2):125. PubMed ID: 35282101 [TBL] [Abstract][Full Text] [Related]
10. A 10-gene signature as a predictor of biochemical recurrence after radical prostatectomy in patients with prostate cancer and a Gleason score ≥7. Wu X; Lv D; Lei M; Cai C; Zhao Z; Eftekhar M; Gu D; Liu Y Oncol Lett; 2020 Sep; 20(3):2906-2918. PubMed ID: 32782607 [TBL] [Abstract][Full Text] [Related]
11. Gene signatures predict biochemical recurrence-free survival in primary prostate cancer patients after radical therapy. Su Q; Liu Z; Chen C; Gao H; Zhu Y; Wang L; Pan M; Liu J; Yang X; Tian J Cancer Med; 2021 Sep; 10(18):6492-6502. PubMed ID: 34453418 [TBL] [Abstract][Full Text] [Related]
12. Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population. Karnes RJ; Bergstralh EJ; Davicioni E; Ghadessi M; Buerki C; Mitra AP; Crisan A; Erho N; Vergara IA; Lam LL; Carlson R; Thompson DJ; Haddad Z; Zimmermann B; Sierocinski T; Triche TJ; Kollmeyer T; Ballman KV; Black PC; Klee GG; Jenkins RB J Urol; 2013 Dec; 190(6):2047-53. PubMed ID: 23770138 [TBL] [Abstract][Full Text] [Related]
13. SAMD5 mRNA was overexpressed in prostate cancer and can predict biochemical recurrence after radical prostatectomy. Li F; Xu Y; Liu RL Int Urol Nephrol; 2019 Mar; 51(3):443-451. PubMed ID: 30739268 [TBL] [Abstract][Full Text] [Related]
14. Association of microRNA-126 expression with clinicopathological features and the risk of biochemical recurrence in prostate cancer patients undergoing radical prostatectomy. Sun X; Liu Z; Yang Z; Xiao L; Wang F; He Y; Su P; Wang J; Jing B Diagn Pathol; 2013 Dec; 8():208. PubMed ID: 24350576 [TBL] [Abstract][Full Text] [Related]
15. Identification and validation of a six immune-related gene signature for prediction of biochemical recurrence in localized prostate cancer following radical prostatectomy. Luan J; Zhang Q; Song L; Wang Y; Ji C; Cong R; Zheng Q; Xu Z; Xia J; Song N Transl Androl Urol; 2021 Mar; 10(3):1018-1029. PubMed ID: 33850736 [TBL] [Abstract][Full Text] [Related]
16. Combined value of validated clinical and genomic risk stratification tools for predicting prostate cancer mortality in a high-risk prostatectomy cohort. Cooperberg MR; Davicioni E; Crisan A; Jenkins RB; Ghadessi M; Karnes RJ Eur Urol; 2015 Feb; 67(2):326-33. PubMed ID: 24998118 [TBL] [Abstract][Full Text] [Related]
17. The practical clinical role of machine learning models with different algorithms in predicting prostate cancer local recurrence after radical prostatectomy. Hu C; Qiao X; Hu C; Cao C; Wang X; Bao J Cancer Imaging; 2024 Feb; 24(1):23. PubMed ID: 38326860 [TBL] [Abstract][Full Text] [Related]
18. [Basement membrane-related gene signature to predict biochemical recurrence in patients with prostate cancer after radical prostatectomy]. Wang ZH; Liu Z; Zhao XD; Hu EY; Chen YH; Xu XF; Xia J; Liu YH; Dong J; Xu S; Cheng W Zhonghua Nan Ke Xue; 2022 Dec; 28(12):1071-1079. PubMed ID: 37846626 [TBL] [Abstract][Full Text] [Related]
19. Prostate Surface Distension and Tumor Texture Descriptors From Pre-Treatment MRI Are Associated With Biochemical Recurrence Following Radical Prostatectomy: Preliminary Findings. Shiradkar R; Ghose S; Mahran A; Li L; Hubbard I; Fu P; Tirumani SH; Ponsky L; Purysko A; Madabhushi A Front Oncol; 2022; 12():841801. PubMed ID: 35669420 [TBL] [Abstract][Full Text] [Related]
20. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis. Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]